Gilead bolsters cancer portfolio with $21 bln acquisition of Immunomedics
Sept 14 (Reuters) - Gilead Sciences Inc will acquire biotech company Immunomedics Inc for $21 billion, a move that will strengthen its cancer portfolio by ...
More from Washington Non-Local Sources
NY Times on Washington
Bruiser the Elk Left His Herd for a Washington Island and Made It Home
Washington Non-Local Sources
•
1d ago
NY Times on Washington
5 Bike Ride Trails in the U.S. That You'll Really Love
Washington Non-Local Sources
•
3d ago
NY Times on Washington
F.B.I. Charges American in Plot Behind Canada's Tumbler Ridge School Shooting
Washington Non-Local Sources
•
Oct 7, 2026
NY Times on Washington
Visiting Llamas and Alpacas at 5 Farms
Washington Non-Local Sources
•
Oct 6, 2026
NY Times on Washington
After a Failed Execution, Scrutiny of the 5 Methods Used to Kill
Washington Non-Local Sources
•
Oct 6, 2026
NY Times on Washington
Mayors Are Filming Videos, Mamdani Style, With Varying Degrees of Cringe
Washington Non-Local Sources
•
Oct 5, 2026
NY Times on Washington
On Breakroom Chronicles, Safeway Workers Serve Nostalgia During Their Lunch Break
Washington Non-Local Sources
•
Sep 30, 2026
NY Times on Washington
Washington Taxed Its Millionaires. Now the Rich Want It Repealed.
Washington Non-Local Sources
•
Sep 27, 2026